Biggest News Aggregation in the World
📰 Allogeneic News

Allogeneic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allogeneic. Real-time updates on events, politics, business and more.

Bone Marrow Transplant: Adult Allogeneic Bone Marrow Transplant | Zulekha Yenepoya Institute of Oncology | Mangaluru News

Learn about the successful adult allogeneic bone marrow transplant performed at Zulekha Yenepoya Institute of Oncology. Find out how a 40-year-old man with relapsed acute myeloid leukaemia underwent a haploidentical transplant and recovered with minimal complications.
Tamil Nadu Indira Putran Dinesh Makunni Rajesh Krishna Sanjeev Jadhav Anusha Hegde

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to invest a total of $50 million to acquire approximately 8.8% of Poseida and to receive a right of exclusive negotiation and first refusal for any potential partnering of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy product candidate for solid tumors Astellas will have the right to designate an obser...
Naoki Okamura Mark Gergen Adam Pearson Poseida Therapeutics Inc Exchange Commission Astellas Pharma Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and... | June 7, 2023
Pascal Touchon Goldman Sachs Atara Biotherapeutics Inc Chief Executive Officer Annual Global Healthcare Conference Atara Biotherapeutics

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B cell Lymphoma at the American Society of Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today presented long-term follow up... | June 5, 2023
United States Christine Cassiano Zachary Roberts Allogene Allo Research Development European Hematology Association

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science